Genter Mary Beth, Goss Kathleen H, Groden Joanna
Department of Environmental Health, ML 670056, 3223 Eden Ave., 144 Kettering, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA.
Toxicol Pathol. 2004 Nov-Dec;32(6):719-25. doi: 10.1080/01926230490885724.
Chloracetanilide herbicides are multisite carcinogens in rodents. Progression of alachlor-induced olfactory tumors in rats is accompanied by cytoplasmic accumulation and nuclear localization of beta-catenin, suggesting activation of Wint signaling. Female CD-1 mice were resistant to alachlor-induced olfactory carcinogenesis. The current studies were performed to determine whether Apc(Min/+) mice, which have activated Wnt signaling due to mutation of the second allele of Apc, would be susceptible to alachlor olfactory carcinogenesis. Female and male Apc(Min/+) mice, as well as Apc(+/+) littermates received alachlor in the diet (260 mg/kg/d) for up to 3 months. Female A/J and C57BL/6J wild-type mice were also treated (for 10 and 14 months, respectively), as these strains vary in sensitivity to many respiratory tract insults. No olfactory mucosal tumors were observed in any of the mice, although alachlor-treated Apc(Min/+) mice developed histological changes similar to those in alachlor-treated rats. Alachlor-treated A/J mice developed pronounced intracellular accumulation of amorphous eosinophilic material in the olfactory mucosa, foci of respiratory-like metaplasia,and hyperplasia of nasal mucus glands. A similar but less intense response was seen in C57BL/6J mice. Mice and rats had equivalent levels of the putative bioactivating enzyme (CYP2A) in olfactory mucosa. and mice had induced hepatic CYP3A and CYP2B enzymes with alachlor treatment, which may increase alachlor elimination. These studies extend previous observations by describing alachlor-induced olfactory mucosal changes in mice and suggest that hepatic metabolic enzyme induction may be responsible for resistance of mice to alachlor-induced olfactory carcinogenesis.
氯乙酰胺类除草剂在啮齿动物中是多部位致癌物。大鼠中由甲草胺诱导的嗅觉肿瘤进展伴随着β-连环蛋白的细胞质积累和核定位,提示Wnt信号通路被激活。雌性CD-1小鼠对甲草胺诱导的嗅觉致癌作用具有抗性。进行当前研究以确定由于Apc第二个等位基因突变而激活了Wnt信号通路的Apc(Min/+)小鼠是否易患甲草胺诱导的嗅觉致癌作用。雌性和雄性Apc(Min/+)小鼠以及Apc(+/+)同窝小鼠在饮食中接受甲草胺(260 mg/kg/天),持续长达3个月。雌性A/J和C57BL/6J野生型小鼠也接受了处理(分别为10个月和14个月),因为这些品系对许多呼吸道损伤的敏感性不同。尽管用甲草胺处理的Apc(Min/+)小鼠出现了与用甲草胺处理的大鼠相似的组织学变化,但在任何小鼠中均未观察到嗅觉黏膜肿瘤。用甲草胺处理的A/J小鼠在嗅觉黏膜中出现了无定形嗜酸性物质的明显细胞内积累、呼吸道样化生灶以及鼻黏液腺增生。在C57BL/6J小鼠中观察到了类似但程度较轻的反应。小鼠和大鼠嗅觉黏膜中假定的生物活化酶(CYP2A)水平相当。并且用甲草胺处理后小鼠诱导了肝脏CYP3A和CYP2B酶,这可能会增加甲草胺的消除。这些研究通过描述甲草胺诱导的小鼠嗅觉黏膜变化扩展了先前的观察结果,并提示肝脏代谢酶的诱导可能是小鼠对甲草胺诱导的嗅觉致癌作用产生抗性的原因。